WINTON GROUP Ltd Takes $6.21 Million Position in Maximus, Inc. $MMS

WINTON GROUP Ltd purchased a new position in shares of Maximus, Inc. (NYSE:MMS) during the third quarter, HoldingsChannel reports. The fund purchased 67,945 shares of the health services provider’s stock, valued at approximately $6,208,000.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Richardson Financial Services Inc. increased its holdings in Maximus by 123.1% in the 3rd quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock valued at $32,000 after buying an additional 192 shares during the period. Cullen Frost Bankers Inc. acquired a new stake in shares of Maximus in the 3rd quarter valued at $38,000. Canada Pension Plan Investment Board bought a new position in shares of Maximus in the 2nd quarter valued at $35,000. Parkside Financial Bank & Trust raised its holdings in shares of Maximus by 21.7% during the 2nd quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock worth $62,000 after buying an additional 157 shares in the last quarter. Finally, GAMMA Investing LLC raised its holdings in shares of Maximus by 13.9% during the 3rd quarter. GAMMA Investing LLC now owns 1,337 shares of the health services provider’s stock worth $122,000 after buying an additional 163 shares in the last quarter. Institutional investors own 97.21% of the company’s stock.

Insider Transactions at Maximus

In related news, CEO Bruce Caswell bought 3,175 shares of the stock in a transaction that occurred on Tuesday, February 10th. The shares were acquired at an average cost of $78.45 per share, with a total value of $249,078.75. Following the completion of the purchase, the chief executive officer directly owned 328,013 shares of the company’s stock, valued at $25,732,619.85. This trade represents a 0.98% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO David Mutryn purchased 1,000 shares of the firm’s stock in a transaction dated Monday, February 9th. The stock was bought at an average cost of $75.62 per share, for a total transaction of $75,620.00. Following the acquisition, the chief financial officer directly owned 40,037 shares in the company, valued at approximately $3,027,597.94. The trade was a 2.56% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Corporate insiders own 1.80% of the company’s stock.

Maximus Trading Down 1.0%

NYSE:MMS opened at $77.26 on Tuesday. The company has a market cap of $4.21 billion, a PE ratio of 11.76 and a beta of 0.59. The firm has a 50-day moving average of $85.58 and a 200-day moving average of $86.06. Maximus, Inc. has a one year low of $64.68 and a one year high of $100.00. The company has a debt-to-equity ratio of 0.88, a current ratio of 2.34 and a quick ratio of 2.34.

Maximus (NYSE:MMS) last released its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.01. Maximus had a return on equity of 25.30% and a net margin of 6.92%.The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.37 billion. During the same period in the prior year, the company posted $1.61 earnings per share. Maximus’s quarterly revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, equities research analysts expect that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were paid a $0.33 dividend. The ex-dividend date was Friday, February 13th. This represents a $1.32 dividend on an annualized basis and a yield of 1.7%. This is a positive change from Maximus’s previous quarterly dividend of $0.30. Maximus’s dividend payout ratio (DPR) is presently 20.09%.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on MMS shares. Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Weiss Ratings cut shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research note on Tuesday, February 24th. Finally, Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 30th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, Maximus presently has an average rating of “Buy”.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.